Early-stage regulatory strategy is becoming a powerful driver of speed, risk reduction, and commercial value in drug ...

Drug discovery has traditionally been slow and expensive, often taking decades and costing manufacturers billions. Traditional methods, while advancing, are hitting limits in tackling the complexities ...